The purpose of this research study is to test the safety of placental stem cells to treat non-healing diabetic foot ulcers.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Number of Injection Sites Bleeding
Timeframe: Month 1
Number of Injection Sites Bleeding
Timeframe: Month 3
Number of Injection Sites Bleeding
Timeframe: Month 6
Number of Injection Sites Bleeding
Timeframe: Month 12
Number of Injection Sites infection/inflammation
Timeframe: Month 1
Number of Injection Sites infection/inflammation
Timeframe: Month 3
Number of Injection Sites infection/inflammation
Timeframe: Month 6
Number of Injection Sites infection/inflammation
Timeframe: Month 12
Number of Injection Sites with damage to surrounding tissue
Timeframe: Month 1
Number of Injection Sites with damage to surrounding tissue
Timeframe: Month 3
Number of Injection Sites with damage to surrounding tissue
Timeframe: Month 6
Number of Injection Sites with damage to surrounding tissue
Timeframe: Month 12
Number of Subjects with pain
Timeframe: Month 1
Number of Subjects with pain
Timeframe: Month 3
Number of Subjects with pain
Timeframe: Month 6
Number of Subjects with pain
Timeframe: Month 12
Number of Subjects with allergic reaction to placental cells
Timeframe: Month 1
Number of Subjects with allergic reaction to placental cells
Timeframe: Month 3
Number of Subjects with allergic reaction to placental cells
Timeframe: Month 6
Number of Subjects with allergic reaction to placental cells
Timeframe: Month 12
Number of Subjects with worsening of wound
Timeframe: Month 1
Number of Subjects with worsening of wound
Timeframe: Month 3
Number of Subjects with worsening of wound
Timeframe: Month 6
Number of Subjects with worsening of wound
Timeframe: Month 12